scispace - formally typeset
M

M. Hennig

Researcher at Technische Universität München

Publications -  41
Citations -  2576

M. Hennig is an academic researcher from Technische Universität München. The author has contributed to research in topics: Catumaxomab & Lacidipine. The author has an hindex of 22, co-authored 39 publications receiving 2493 citations.

Papers
More filters
Journal ArticleDOI

Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial

TL;DR: The greater efficacy of lacidipine on carotid IMT progression and number of plaques per patient, despite a smaller ambulatory blood pressure reduction, indicates an antiatherosclerotic action of lacIDipine independent of its antihypertensive action.
Journal ArticleDOI

Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA).

TL;DR: This is the first demonstration from a large database that not only average 24 h PP and SBP values, but also 24 h BP fluctuations, are associated with, and possibly determinants of, the alterations of large artery structure in hypertension.
Journal ArticleDOI

Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).

TL;DR: ELSA shows that carotid intima-media thickening and plaques are important added risks of cardiovascular outcomes in a treated hypertensive population independently of blood pressure and traditional risk factors, but the analysis failed to show a predictive role of treatment-dependent IMT changes.